And care and heed the counsel of experts. “We are working with NHS England to open new gender identity services, so people can access holistic health and wellbeing support they need.”
“We are setting up a clinical trial into the use of puberty blockers next year, to establish a clear evidence base for the use of this medicine.”
The head of the Cass Review on gender healthcare for kids, Dr. Hilary Cass, called puberty blockers “powerful drugs with unproven benefits and significant risks.”
She further explained: “That is why I recommended that they should only be prescribed following a multi-disciplinary assessment and within a research protocol.”
In addition, she expressed her support for the government’s decision, saying: “I support the Government’s decision.
To continue restrictions on the dispensing of puberty blockers for gender dysphoria outside the NHS where these essential safeguards are not being provided.”
The British Medical Association (BMA) stirred up controversy last year when it reacted negatively to the Cass Review’s findings, promising to “publicly critique”
The results and support transgender youngsters. The BMA said that “victimised” transgender youngsters will suffer as a result of the prohibition on puberty blockers.
In a secret meeting earlier this month, the BMA’s governing council decided to take action; but, specifics were not made public until later.
